Security Snapshot

MINERALYS THERAPEUTICS INC - CALL Institutional Ownership

CUSIP: 603170901

13F Institutional Holders and Ownership History from Q2 2024 to Q4 2025

Latest Period

Q4 2025

Institutions Reporting

1

Shares (Excl. Options)

50,000

Price

$36.29

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Type / Class
Equity / CALL
Price per share
$36.29
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
50,000
Total reported value
$1,814,000
% of total 13F portfolios
0%
Share change
+50,000
Value change
+$1,814,000
Number of holders
1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • 603170901 - MINERALYS THERAPEUTICS INC - CALL is tracked under CUSIP 603170901.
  • 1 institution reported positions in Q4 2025.
  • Schedule 13D/13G significant owner rows are not currently available.

What Changed

  • Holder count moved from 0 to 1 between Q3 2025 and Q4 2025.
  • Reported value moved from to $1,814,000.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 1 institution filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 603170901?
CUSIP 603170901 identifies 603170901 - MINERALYS THERAPEUTICS INC - CALL in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

As of 31 Dec 2025, 1 institutional investors reported holding 50,000 shares of MINERALYS THERAPEUTICS INC - CALL.

Institutional Holders of MINERALYS THERAPEUTICS INC - CALL across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 50,000 $1,814,000 +$1,814,000 $36.29 1
2025 Q3 $37.83 0
2025 Q2 $13.43 0
2025 Q1 $15.82 0
2024 Q4 $10.00 0
2024 Q3 $11.43 0
2024 Q2 $11.25 0
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .